Women in Science: CEO of AltruBio Judy Chou
As well as CEO, Judy Chou is also president, and her role is centered around addressing unmet medical needs in immunological diseases.
Source: biopharma-reporter.com
Page 25 - Bio Developments News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bio Developments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bio Developments Today - Breaking & Trending Today
Not to be missed - our patient centricity in action webinar
Outsourcing Pharma is delighted to invite you to join our not-to-be-missed webinar on one of the most important areas of the industry – patient centricity – and its solutions.
Source: biopharma-reporter.com
AbbVie buys ImmunoGen for $10.1 billion, expanding cancer drug portfolio
AbbVie is acquiring rival biotech firm ImmunoGen for $10.1 billion, giving it access to ImmunoGen's flagship ovarian cancer treatment Elahere, which was granted accelerated approval from the FDA last year.
Source: biopharma-reporter.com
Lumen Bioscience bags $5.5 million to develop needle-free vaccines
Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for highly prevalent disease, has received $5.5 million in new funding from the U.S. Department of Defense, to develop technologies for needle-free vaccines.
Source: biopharma-reporter.com
PlaqueTec recruits first ten patients in cardiovascular disease trial
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), has received approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.
Source: biopharma-reporter.com